Download Files:
Products Details
Product Description
– LA-Bac8c is a Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. LA-Bac8c inhibits S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa with MICs of 1, 4, 8, 8, and 8 μg/mL[1].
Web ID
– HY-146133
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C65H102N20O9S2
References
– [1]Wenya Zhou, et al. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorg Med Chem. 2020 Oct 1;28(19):115682.
Molecular Weight
– 1371.76
SMILES
– O=C([C@@H](NC(CCCCC1CSCS1)=O)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC2=CNC3=CC=CC=C23)=O)[C@H](CC)C)=O)C(C)C)=O)CC4=CNC5=CC=CC=C45)=O)[C@H](CC)C
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Antibiotic;Bacterial
Pathway
– Anti-infection
Product type
– Peptides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
